Sfoglia per AUTORE
BAUDIN E
Collezione AOU San Luigi di Orbassano

  

Items : 10

Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):631. doi: 10.1016/j.annonc.2022.12.006. Epub 2022 Dec 21.
2023
AOU San Luigi di Orbassano

Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A; Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;

Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2167-e2176. doi: 10.1210/clinem/dgab899.
2022
AOU San Luigi di Orbassano

Cosentini D; Grisanti S; Hadoux J; Libè R; Frigerio M; Laganà M; Deschamps F; Zamparini M; Lamartina L; Pedersini R; Valsecchi C; Maroldi R; Al Ghuzlan A; Terzolo M; Gasparotti R; Baudin E; Berruti A;

ENSAT registry-based randomized clinical trials for adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2021 Feb;184(2):R51-R59. doi: 10.1530/EJE-20-0800.
2021
AOU San Luigi di Orbassano

Crona J; Baudin E; Terzolo M; Chrisoulidou A; Angelousi A; Ronchi CL; Oliveira CL; Nieveen van Dijkum EJM; Ceccato F; Borson-Chazot F; Reimondo G; Tiberi GAM; Ettaieb H; Kiriakopoulos A; Canu L; Kastelan D; Osher E; Yiannakopoulou E; Arnaldi G; Assié G; Paiva I; Bourdeau I; Newell-Price J; Nowak KM; Romero MT; De Martino MC; Bugalho MJ; Sherlock M; Vantyghem MC; et alii...

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Nov;31(11):1476-1490. doi: 10.1016/j.annonc.2020.08.2099. Epub 2020 Aug 27.
2020
AOU San Luigi di Orbassano

Fassnacht M; Assie G; Baudin E; Eisenhofer G; de la Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;

Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. in European journal of endocrinology / Eur J Endocrinol. 2019 May 1;180(5):311-320. doi: 10.1530/EJE-19-0026.
2019
AOU San Luigi di Orbassano

Berruti A; Libè R; Laganà M; Ettaieb H; Sukkari MA; Bertherat J; Feelders RA; Grisanti S; Cartry J; Mazziotti G; Sigala S; Baudin E; Haak H; Habra MA; Terzolo M;

2018
AOU San Luigi di Orbassano

Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M;

2017
AOU San Luigi di Orbassano

Ferolla P; Brizzi MP; Meyer T; Mansoor W; Mazieres J; Do Cao C; Léna H; Berruti A; Damiano V; Buikhuisen W; Grønbæk H; Lombard-Bohas C; Grohé C; Minotti V; Tiseo M; De Castro J; Reed N; Gislimberti G; Singh N; Stankovic M; Öberg K; Baudin E;

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. in European urology / Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14.
2014
AOU San Luigi di Orbassano

Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M; Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; et alii...

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231.
2012
AOU San Luigi di Orbassano

Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G;

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2012 Mar;166(3):451-8. doi: 10.1530/EJE-11-0918. Epub 2011 Dec 21.
2012
AOU San Luigi di Orbassano

Berruti A; Sperone P; Ferrero A; Germano A; Ardito A; Priola AM; De Francia S; Volante M; Daffara F; Generali D; Leboulleux S; Perotti P; Baudin E; Papotti M; Terzolo M;